about
Global epidemiology of tuberculosisImplementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections studyProspects for Tuberculosis EliminationGlobal tuberculosis control: lessons learnt and future prospects.The effect of tuberculosis on mortality in HIV positive people: a meta-analysis.Chronic diarrhea, hemorrhagic colitis, and hemolytic-uremic syndrome associated with HEp-2 adherent Escherichia coli in adults infected with human immunodeficiency virus in Bangui, Central African RepublicCorrelation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection.Assessing tuberculosis case fatality ratio: a meta-analysis.Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention.WHO guidance on electronic systems to manage data for tuberculosis care and control.Antiretroviral therapy for tuberculosis control in nine African countries.Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countriesTuberculosis mortality in HIV-infected individuals: a cross-national systematic assessmentUsing the TIME model in Spectrum to estimate tuberculosis-HIV incidence and mortality.Analysis of tuberculosis prevalence surveys: new guidance on best-practice methods.Global epidemiology of tuberculosis.Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortalityTowards tuberculosis elimination: an action framework for low-incidence countriesSurveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010Multidrug-resistant tuberculosis in children: evidence from global surveillance.Global burden and epidemiology of tuberculosis.Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts.Estimating tuberculosis case detection rate in resource-limited countries: a capture-recapture study in Egypt.The epidemiology of ciguatera fish poisoning.Estimating the tuberculosis burden in resource-limited countries: a capture-recapture study in Yemen.Secondary dengue virus type 4 infections in Vietnam.Results of a safety trial on single-dose treatments with 400 mcg/kg of ivermectin in bancroftian filariasis.National tuberculosis prevalence surveys in Asia, 1990-2012: an overview of results and lessons learned.Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro.Variation in the vector competence of Aedes polynesiensis for Wuchereria bancrofti.Knowledge, attitudes and practices of university students regarding HIV infection, in Phnom Penh, Cambodia, 1999.Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia.Emergence of cholera in the Central African Republic.The burden of tuberculosis disease in children.Tuberculosis prevalence surveys: rationale and cost.Estimating tuberculosis burden and reporting in resource-limited countries: a capture-recapture study in Iraq.Moving the goalposts for tuberculosis targets in Africa.Etiologies of acute, persistent, and dysenteric diarrheas in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus.Reverse transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV Type 1 perinatal transmission.
P50
Q27022861-99DE4247-B5FC-45A3-99DE-773E3C0409CBQ28480516-B6978483-8325-4DDE-A2E3-1FFB83D9A842Q29392153-17D78F13-3AE8-4A4C-B430-9F1E34B0E368Q30416689-5618593B-011F-486C-9E77-09A98CB2D70BQ30994512-9DF419CF-7D0B-44F2-877A-893F001216F4Q33343452-CCCF129C-A6FF-4402-8A9F-17E08E6FEFADQ33491193-AB2AC55B-3603-4974-9A95-29A811168899Q33954598-F1BA9C7C-DAFD-440E-AFBA-1331DC0CFEB8Q34226104-73678D6E-8E3D-47B3-B8A3-49E751870267Q34315927-7AA6F4B8-350A-449F-BB38-AB876FDE78B5Q34320245-C0CE5D99-4B4D-4DDB-9E5D-87F17DEFDFDDQ34441930-57A67271-201D-486C-9496-5FF4EB172E1DQ34560360-B9C1F0E4-72B7-4469-ADDC-D7585B92333AQ34585091-4BF06627-1C2B-4AD5-8CDD-E5F172A10214Q35001454-82A7F02C-7570-4A17-B6F0-969EA7F9E9C5Q35045088-06FFC4DD-8F71-4925-A7BA-7503483E24BCQ35149050-235B4AF7-701B-4BC6-BF0A-F8528BEE8028Q35344151-6382F70B-E23B-4E6A-9A91-0522314C9CB5Q35826942-F8766573-3CB9-41D5-ADDE-8F5D376D645EQ37137678-5F3D91C6-68C1-4056-87A0-BDD6460AD18DQ37635376-7F1747F6-AD02-4F3C-908D-F288DEBD38ACQ37912290-B369F816-E76B-4AD1-ACC4-2E326032146DQ38093325-C554EDAF-22C3-4291-B55F-603A86176A00Q38895843-C1178AF5-AF70-4BF6-84C4-C716F0156C9FQ39025074-FD826D24-CC55-4DBE-B355-ACBFB8B0D0CFQ39197665-97E50F97-F09E-4ED4-8CDA-D579C25D55E1Q40508045-0864681D-1AD4-4DFD-B442-586A2CB8A1ECQ40726446-143EC3AA-E602-435E-8E7F-9B7AB7891BEFQ40974691-55C36BF8-EA9D-4893-B649-E42C196E53B6Q41913365-F37056D8-BD1F-4B21-891F-F59545FBB046Q43037879-466AFA2D-E14D-4DC6-AC68-B083412E30FAQ43679634-EAF6AB48-E117-49F8-926B-5DFA01719F13Q44244119-945DB7DF-C8F0-44FC-A191-B21034DF76FEQ44405071-30C07457-BE2D-43EF-9BE5-3D84B12F2E56Q44589030-1FA16B02-7C2C-4924-B6DA-FB9977DD88E0Q44626351-DC90B728-4CEF-4E32-A8CD-9B82DE3E1A17Q45173174-008747CC-D298-4A06-A50D-986A022A42CFQ45434595-C4C206B6-6A1A-4C08-B2A1-6FEBAA14FFBBQ45751804-E2925085-D7C7-475E-BB8F-74080D640494Q46832845-4E8620A2-F06B-4FC1-8643-D00E5E313CCB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Philippe Glaziou
@ast
Philippe Glaziou
@en
Philippe Glaziou
@es
Philippe Glaziou
@nl
Philippe Glaziou
@sl
type
label
Philippe Glaziou
@ast
Philippe Glaziou
@en
Philippe Glaziou
@es
Philippe Glaziou
@nl
Philippe Glaziou
@sl
prefLabel
Philippe Glaziou
@ast
Philippe Glaziou
@en
Philippe Glaziou
@es
Philippe Glaziou
@nl
Philippe Glaziou
@sl
P106
P21
P31
P496
0000-0002-0649-1272